ADA Scientific Sessions 2025 Abstract

Robust Antiobesity Effect and Mechanistic Insights of HM15275, a Novel Long-Acting GLP-1/GIP/Glucagon Triple Agonist in Animal Model of Obesity

By Sang Hyun Park, Yohan Kim, Jung Kuk Kim, In Young Choi

Experiments in animalsInterventions

The paper

Sang Hyun Park, Yohan Kim, Jung Kuk Kim, In Young Choi

Hwaseong-si

ADA Scientific Sessions 2025 Abstract, 13 Jun 2025

Presented at ADA Scientific Sessions 2025, poster 774-P

doi.org/10.2337/db25-774-p

Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial
The New England Journal of Medicine4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity
JCI Insight6 Oct 2026
Antibody reduced fat while preserving lean mass in mice
Lancet4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes